2024, Número 4
Physical Comorbidity and Healthcare Utilization in People with Schizophrenia: a systematic review
Idioma: Español
Referencias bibliográficas: 92
Paginas: 189-204
Archivo PDF: 307.23 Kb.
RESUMEN
Introducción. La esquizofrenia puede provocar una discapacidad significativa y tener un impacto notable en el funcionamiento social y ocupacional. Este trastorno tiende a disminuir la esperanza de vida debido a una variedad de factores, incluidos malos hábitos de salud, obstáculos para acceder a la atención médica y el estigma a las enfermedades mentales. Objetivo. La presente revisión sistemática pretende examinar la comorbilidad física de estos pacientes y su uso de los servicios de salud. Método. El protocolo registrado en la base de datos PROSPERO (CRD42020139972) sigue las directrices Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). A través de PubMed/MEDLINE, EMBASE, Scopus, Web of Science, PsycINFO, Cochrane Library y ProQuest Health Research Premium Collection se identificaron 317 artículos y se seleccionaron 57. Resultados. Las personas que padecen esquizofrenia se enfrentan a una tasa de mortalidad que supera al menos el doble de la población general, y son susceptibles a enfermedades cardiovasculares, respiratorias, diabetes mellitus, oncológicas e infecciones crónicas, que pueden disminuir su esperanza de vida. Las complicaciones durante la hospitalización y las estancias prolongadas dificultan su atención sanitaria. Discusión y conclusión. Los sistemas de salud requieren mejoras para brindar una atención adecuada a los pacientes con esquizofrenia y ayudar a incrementar su esperanza de vida. Además, estos pacientes se benefician de adoptar estilos de vida saludables, tratar la dependencia de sustancias y adaptar el tratamiento antipsicótico. Parece crucial ejecutar estrategias de intervención y capacitar a los profesionales clínicos para poder detectar y manejar las comorbilidades físicas asociadas a este trastorno mental.REFERENCIAS (EN ESTE ARTÍCULO)
Bauer-Staeb, C., Jörgensen, L., Lewis, G., Dalman, C., Osborn, D. P. J., & Hayes, J. F.(2017). Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in peoplewith severe mental illness: a total population study of Sweden. The Lancet -Psychiatry, 4(9), 685-693. https://doi.org/10.1016/S2215-0366(17)30253-5
Bernardo, M., Rico-Villademoros, F., García-Rizo, C., Rojo, R., & Gómez-Huelgas,R. (2021). Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients:A Systematic Review of Population-Based Studies. Advances in Therapy, 38(5),2491-2512. https://doi.org/10.1007/s12325-021-01689-8
Bitter, I., Czobor, P., Borsi, A., Fehér, L., Nagy, B. Z., Bacskai, M., Rakonczai,P., Hegyi, R., Németh, T., Varga, P., Gimesi-Országh, J., Fadgyas-Freyler,P., Sermon, J., … Takács, P. (2017). Mortality and the relationship ofsomatic comorbidities to mortality in schizophrenia. A nationwide matchedcohortstudy. European psychiatry, 45, 97-103. https://doi.org/10.1016/j.eurpsy.2017.05.022
Brink, M., Green, A., Bojesen, A. B., Lamberti, J. S., Conwell, Y., & Andersen, K.(2017). Physical Health, Medication, and Healthcare Utilization among 70-Year-Old People with Schizophrenia: A Nationwide Danish Register Study. AmericanJournal of Geriatric Psychiatry, 25(5), 500-509. doi: 10.1016/j.jagp.2016.12.015
Chen, P. H., Tsai, S. Y., Pan, C. H., Chang, H. M., Chen, Y. L., Su, S. S., Chen. C.C., & Kuo, C. J. (2021). Age Effect on Incidence, Physical, and PsychiatricComorbidity for Sudden Cardiac Death in Schizophrenia: Effet de l’âge surl’incidence, la comorbidité physique et psychiatrique de la mort cardiaque subitedans la schizophrénie. Canadian Journal of Psychiatry / Revue Canadienne dePsychiatrie, 66(4), 367-375. https://doi.org/10.1177/0706743720948429
Cloutier, M., Aigbogun, M. S., Guerin, A., Nitulescu, R., Ramanakumar, A. V.,Kamat, S. A., DeLucia, M., Duffy, R., Legacy, S. N., Henderson, C., Francois,C., & Wu, E. (2016). The Economic Burden of Schizophrenia in the UnitedStates in 2013. The Journal of Clinical Psychiatry, 77(6), 764-771. https://doi.org/10.4088/JCP.15m10278
Correll, C. U., Solmi, M., Croatto, G., Schneider, L. K., Rohani-Montez, S. C.,Fairley, L., Smith, N., Bitter, I., Gorwood, P., Taipale, H., & Tiihonen, J. (2022).Mortality in people with schizophrenia: a systematic review and meta-analysisof relative risk and aggravating or attenuating factors. World Psychiatry, 21(2),248-271. https://doi.org/10.1002/wps.20994
Dalton, S. O., Suppli, N. P., Ewertz, M., Kroman, N., Grassi, L., & Johansen, C. (2018).Impact of schizophrenia and related disorders on mortality from breast cancer:A population-based cohort study in Denmark, 1995-2011. Breast (Edinburgh,Scotland), 40, 170-176. https://doi.org/10.1016/j.breast.2018.06.002
DE Hert, M., Correll, C. U., Bobes, J., Cetkovich-Bakmas, M., Cohen, D., Asai, I.,Detraux, J., Gautam, S., Möller, H. J., Ndetei, D. M., Newcomer, J. W., Uwakwe,R., & Leucht, S. (2011). Physical illness in patients with severe mental disorders.I. Prevalence, impact of medications and disparities in health care. WorldPsychiatry, 10(1), 52-77. https://doi.org/10.1002/j.2051-5545.2011.tb00014.x
Douzenis, A., Seretis, D., Nika, S., Nikolaidou, P., Papadopoulou, A., Rizos, E. N.,Christodoulou, C., Tsopelas, C., Mitchell, D., & Lykouras, L. (2012). Factorsaffecting hospital stay in psychiatric patients: the role of active comorbidity.BMC Health Services Research, 12, 166. https://doi.org/10.1186/1472-6963-12-166
Fond, G., Salas, S., Pauly, V., Baumstarck, K., Bernard, C., Orleans, V., Llorca, P. M.,Lancon, C., Auquier, P., & Boyer, L. (2019). End-of-life care among patientswith schizophrenia and cancer: a population-based cohort study from the Frenchnational hospital database. The Lancet - Public Health, 4(11), e583-e591.https://doi.org/10.1016/S2468-2667(19)30187-2
Gabilondo, A., Alonso-Moran, E., Nuño-Solinis, R., Orueta, J. F., & Iruin, A.(2017). Comorbidities with chronic physical conditions and gender profilesof illness in schizophrenia. Results from PREST, a new health dataset.Journal of Psychosomatic Research, 93, 102-109. https://doi.org/10.1016/j.jpsychores.2016.12.011
Goueslard, K., Petit, J. M., Cottenet, J., Chauvet-Gelinier, J. C., Jollant, F., &Quantin, C. (2018). Increased Risk of Rehospitalization for Acute DiabetesComplications and Suicide Attempts in Patients with Type 1 Diabetes andComorbid Schizophrenia. Diabetes Care, 41(11), 2316-2321. https://doi.org/10.2337/dc18-0657
Gur, S., Weizman, S., Stubbs, B., Matalon, A., Meyerovitch, J., Hermesh, H., &Krivoy, A. (2018). Mortality, morbidity and medical resources utilization ofpatients with schizophrenia: A case-control community-based study. PsychiatryResearch, 260, 177-181. https://doi.org/10.1016/j.psychres.2017.11.042
Gyllensten, A. L., Ovesson, M. N., Hedlund, L., Ambrus, L., & Tornberg, Å.(2020). To increase physical activity in sedentary patients with affective - orschizophrenia spectrum disorders - a clinical study of adjuvant physical therapyin mental health. Nordic Journal of Psychiatry, 74(1), 73-82. https://doi.org/10.1080/08039488.2019.1669706
Hauck, T. S., Liu, N., Wijeysundera, H. C., & Kurdyak, P. (2020). Mortalityand Revascularization among Myocardial Infarction Patients withSchizophrenia: A Population-Based Cohort Study. Canadian Journal ofPsychiatry / Revue Canadienne de Psychiatrie, 65(7), 454-462. https://doi.org/10.1177/0706743720904845
Hayes, J. F., Marston, L., Walters, K., King, M. B., & Osborn, D. P. J. (2017).Mortality gap for people with bipolar disorder and schizophrenia: UK-basedcohort study 2000-2014. The British Journal of Psychiatry: The Journal ofMental Science, 211(3), 175-181. https://doi.org/10.1192/bjp.bp.117.202606
Heiberg, I. H., Jacobsen, B. K., Balteskard, L., Bramness, J. G., Naess, Ø., Ystrom,E., Reichborn-Kjennerud, T., Hultman, C. M., Nesvåg, R., & Høye, A. (2019).Undiagnosed cardiovascular disease prior to cardiovascular death in individualswith severe mental illness. Acta Psychiatrica Scandinavica, 139(6), 558-571.https://doi.org/10.1111/acps.13017
Ishikawa, H., Yasunaga, H., Matsui, H., Fushimi, K., & Kawakami, N. (2016).Differences in cancer stage, treatment and in-hospital mortality between patientswith and without schizophrenia: retrospective matched-pair cohort study. TheBritish Journal of Psychiatry: The Journal of Mental Science, 208(3), 239-244.https://doi.org/10.1192/bjp.bp.114.156265
Jørgensen, M., Mainz, J., Lange, P., & Paaske Johnsen, S. (2018). Quality of careand clinical outcomes of chronic obstructive pulmonary disease in patients withschizophrenia. A Danish nationwide study. International Journal for Quality inHealth Care, 30(5), 351-357. https://doi.org/10.1093/intqhc/mzy014
Korpela, H., Miettunen, J., Rautio, N., Isohanni, M., Järvelin, M. R., Jääskeläinen,E., Auvinen, J., Keinänen-Kiukaanniemi, S., Nordström, T., & Seppälä, J.(2020). Early environmental factors and somatic comorbidity in schizophreniaand nonschizophrenic psychoses: A 50-year follow-up of the Northern FinlandBirth Cohort 1966. European Psychiatry, 63(1), e24. https://doi.org/10.1192/j.eurpsy.2020.25
Laursen, T. M., Plana-Ripoll, O., Andersen, P. K., McGrath, J. J., Toender, A., Nordentoft,M., Canudas-Romo, V., & Erlangsen, A. (2019). Cause-specific life years lost amongpersons diagnosed with schizophrenia: Is it getting better or worse? SchizophreniaResearch, 206, 284-290. https://doi.org/10.1016/j.schres.2018.11.003
Lu, M. L. R., De Venecia, T. A., Goyal, A., Rodriguez Ziccardi, M., Kanjanahattakij,N., Shah, M. K., Davila, C. D, & Figueredo, V. M. (2017). Psychiatricconditions as predictors of rehospitalization among African American patientshospitalized with heart failure. Clinical Cardiology, 40(11), 1020-1025. https://doi.org/10.1002/clc.22760
Martinez-Nicolas, I., Basaraba, C., Delgado-Gomez, D., Lopez-Fernandez, O., Baca-Garcia, E., Wainberg, M. L. (2023b). The Electronic Mental Wellness Tool asa Self-Administered Brief Screening Instrument for Mental Disorders in theGeneral Spanish Population during the Post-COVID-19 Era. InternationalJournal of Environmental Research and Public Health, 20(4), 3204. https://doi.org/10.3390/ijerph20043204
Martínez-Nicolás, I., Molina-Pizarro, C.A., Franco, A.R., Arenas Castañeda, P. E.,Maya, C., Barahona, I., Martínez-Alés, G., Aroca Bisquert, F., Delgado-Gomez,D., Dervic, K., Lopez-Fernandez, O., Baca-García, E., & Barrigón, M. L.(2023a). What seems to explain suicidality in Yucatan Mexican young adults?Findings from an app-based mental health screening test using the SMARTSCREENprotocol. Current Psychology, 42(35), 30767-30779). https://doi.org/10.1007/s12144-022-03686-8
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C.D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville,J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., ... Moher, D. (2021). The PRISMA 2020 statement:an updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
Partti, K., Vasankari, T., Kanervisto, M., Perälä, J., Saarni, S. I., Jousilahti, P.,Lönnqvist, J., & Suvisaari, J. (2015). Lung function and respiratory diseasesin people with psychosis: population-based study. The British Journal ofPsychiatry, 207(1), 37-45. https://doi.org/10.1192/bjp.bp.113.141937
Polcwiartek, C., Kragholm, K., Rohde, C., Hashemi, N., Vang, T., & Nielsen, J.(2017). Diabetic ketoacidosis and diabetes associated with antipsychoticexposure among a previously diabetes-naive population with schizophrenia: anationwide nested case-control study. Diabetologia, 60(9), 1678-1690. https://doi.org/10.1007/s00125-017-4320-5
Schoepf, D., Potluri, R., Uppal, H., Natalwala, A., Narendran, P., & Heun, R. (2012).Type-2 diabetes mellitus in schizophrenia: increased prevalence and majorrisk factor of excess mortality in a naturalistic 7-year follow-up. EuropeanPsychiatry, 27(1), 33-42. https://doi.org/10.1016/j.eurpsy.2011.02.009
Schoepf, D., Uppal, H., Potluri, R., & Heun, R. (2014). Physical comorbidity andits relevance on mortality in schizophrenia: a naturalistic 12-year follow-upin general hospital admissions. European Archives of Psychiatry and ClinicalNeuroscience, 264(1), 3-28. https://doi.org/10.1007/s00406-013-0436-x
Schulman-Marcus, J., Goyal, P., Swaminathan, R. V., Feldman, D. N., Wong, S. C.,Singh, H. S., Minutello, R. M., Bergman, G., & Kim, L. K. (2016). Comparisonof Trends in Incidence, Revascularization, and In-Hospital Mortality in STElevationMyocardial Infarction in Patients with Versus Without Severe MentalIllness. The American Journal of Cardiology, 117(9), 1405-1410. https://doi.org/10.1016/j.amjcard.2016.02.006
Soontornniyomkij, V., Lee, E. E., Jin, H., Martin, A. S., Daly, R. E., Liu, J., Tu, X.M., Eyler, L. T., & Jeste, D. V. (2019). Clinical Correlates of Insulin Resistancein Chronic Schizophrenia: Relationship to Negative Symptoms. Frontiers inPsychiatry, 10, 251. https://doi.org/10.3389/fpsyt.2019.00251
Sørensen, H. J., Nielsen, P. R., Benros, M. E., Pedersen, C. B., & Mortensen,P. B. (2015). Somatic diseases and conditions before the first diagnosis ofschizophrenia: a nationwide population-based cohort study in more than900 000 individuals. Schizophrenia Bulletin, 41(2), 513-521. https://doi.org/10.1093/schbul/sbu110
Spilsbury, K., Rosenwax, L., Brameld, K., Kelly, B., & Arendts, G. (2018). Morbidityburden and community-based palliative care are associated with rates of hospitaluse by people with schizophrenia in the last year of life: A population-basedmatched cohort study. PloS One, 13(11), e0208220. https://doi.org/10.1371/journal.pone.0208220
Urrútia, G., & Bonfill, X. (2010). Declaración PRISMA: una propuesta para mejorarla publicación de revisiones sistemáticas y metaanálisis [PRISMA declaration: aproposal to improve the publication of systematic reviews and meta-analyses].Medicina Clínica, 135(11), 507-511. https://doi.org/10.1016/j.medcli.2010.01.015
Vancampfort, D., Firth, J., Schuch, F. B., Rosenbaum, S., Mugisha, J., Hallgren,M., Probst, M., Ward, P. B., Gaughran, F., De Hert, M., Carvalho, A. F., &Stubbs, B. (2017). Sedentary behavior and physical activity levels in peoplewith schizophrenia, bipolar disorder and major depressive disorder: a globalsystematic review and meta-analysis. World Psychiatry, 16(3), 308-315. https://doi.org/10.1002/wps.20458